Gas6 has primarily been shown to be a macrophage-derived factor that activates Axl in mouse models of breast cancer, and Warfarin, an anticoagulant that blocks the interaction between Gas6 and Axl, has recently been proposed as a cancer prevention strategy30,31. The gene discussed is AXL; the disease is breast cancer.